# Metoprolol Succinate in Cardiac Remodeling Related to Cirrhosis

Study · id `cardio:ct-nct01676285` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01676285](<https://clinicaltrials.gov/study/NCT01676285>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01676285

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 125 participants.

## Technical summary

Registry record NCT01676285. Randomized; quadruple masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2013-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 125 participants (enrolled count; ClinicalTrials.gov record NCT01676285, source copy `cardio:ctgov-nct01676285-2014-09-11`, retrieved 2026-10-31)
- Start date: 2012-01 (registry gives no type) (ClinicalTrials.gov record NCT01676285, source copy `cardio:ctgov-nct01676285-2014-09-11`, retrieved 2026-10-31)
- Primary completion: 2013-09 (actual) (ClinicalTrials.gov record NCT01676285, source copy `cardio:ctgov-nct01676285-2014-09-11`, retrieved 2026-10-31)
- Completion: 2014-03 (actual) (ClinicalTrials.gov record NCT01676285, source copy `cardio:ctgov-nct01676285-2014-09-11`, retrieved 2026-10-31)
- Countries: Brazil (ClinicalTrials.gov record NCT01676285, source copy `cardio:ctgov-nct01676285-2014-09-11`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01676285-2014-09-11`, retrieved 2026-10-31)

## The registry's words

- Brief title: Metoprolol Succinate in Cardiac Remodeling Related to Cirrhosis
- Acronym: CARE Cirrhosis
- Condition: Cirrhosis
- Condition: Cirrhotic Cardiomyopathy
- Condition: Cardiac Remodeling
- Intervention (Drug): Metoprolol succinate
- Intervention (Drug): placebo
- Lead sponsor: University of Sao Paulo
- Lead sponsor class: OTHER
- Collaborator: Fundação de Amparo à Pesquisa do Estado de São Paulo
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Cardiomyopathy (heart muscle disease) (`cardio:cardiomyopathy`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Metoprolol (`cardio:metoprolol`)
- Registry intervention is a member of this class by a sourced record link: Beta-blockers (drug class) (`cardio:beta-blockers`)
- Registry lists this organization as the lead sponsor: University of Sao Paulo (`cardio:org-university-of-sao-paulo`)
- Registry lists this organization as a collaborator: Fundação de Amparo à Pesquisa do Estado de São Paulo (`cardio:org-fundacao-de-amparo-a-pesquisa-do-estado-de-sao-paulo`)

## Provenance

Content hash: d55a8a5225459f8b43797add6bf208cca2bb2a82b3bc40af878a843dbd033a12
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
